US CDC blames Hib death on vaccine rebels

9 February 2009

The US Centers for Disease Control and Prevention (CDC) has issued a report on invasive Haemophilius influenzae type b (Hib) disease in five  Minnesota children, one of whom died in 2008. Although one of the  vaccines that should have been available was the object of a product  recall in December 2007, supplies of two other products manufactured by  France's Sanofi Pasteur were "adequate for all infants to complete the  three-dose primary vaccine series," the agency said. Three of the  affected children, including the fatal case, had received no Hib  immunization at all.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK







Today's issue

Company Spotlight